570 related articles for article (PubMed ID: 30390806)
1. Screening Library Design.
Ashenden SK
Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
[TBL] [Abstract][Full Text] [Related]
2. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
[TBL] [Abstract][Full Text] [Related]
3. Screening of a virtual mirror-image library of natural products.
Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Ohno H; Osada H; Fujii N
Chem Commun (Camb); 2016 Jun; 52(49):7653-6. PubMed ID: 27198617
[TBL] [Abstract][Full Text] [Related]
4. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic assays for chemical biology and drug discovery.
Gul S
Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
[TBL] [Abstract][Full Text] [Related]
6. Acoustic droplet ejection facilitates cell-based high-throughput screenings using natural products.
Mackenzie TA; Tormo JR; Cautain B; Martínez G; Sánchez I; Genilloud O; Vicente F; Ramos MC
SLAS Technol; 2024 Jun; 29(3):100111. PubMed ID: 37898289
[TBL] [Abstract][Full Text] [Related]
7. Benefits of Strategic Small-Scale Targeted Screening.
Sharlow ER
Assay Drug Dev Technol; 2016 Aug; 14(6):329-32. PubMed ID: 27341343
[TBL] [Abstract][Full Text] [Related]
8. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
Roy A; McDonald PR; Sittampalam S; Chaguturu R
Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
[TBL] [Abstract][Full Text] [Related]
9. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
[TBL] [Abstract][Full Text] [Related]
10. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
Liu M; Quinn RJ
Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
[No Abstract] [Full Text] [Related]
11. The polypharmacology of natural products.
Ho TT; Tran QT; Chai CL
Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
[TBL] [Abstract][Full Text] [Related]
12. Hit-to-Lead: Hit Validation and Assessment.
Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
[TBL] [Abstract][Full Text] [Related]
13. Chemical screening in zebrafish for novel biological and therapeutic discovery.
Wiley DS; Redfield SE; Zon LI
Methods Cell Biol; 2017; 138():651-679. PubMed ID: 28129862
[TBL] [Abstract][Full Text] [Related]
14. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
Stork C; Kirchmair J
Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
[No Abstract] [Full Text] [Related]
15. A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings.
Zhao C; Ye Z; Ma ZX; Wildman SA; Blaszczyk SA; Hu L; Guizei IA; Tang W
Nat Commun; 2019 Sep; 10(1):4015. PubMed ID: 31488839
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel scaffolds for Rho kinase 2 inhibitor through TRFRET-based high throughput screening assay.
Oh KS; Mun J; Cho JE; Lee S; Yi KY; Lim CJ; Lee JS; Park WJ; Lee BH
Comb Chem High Throughput Screen; 2013 Jan; 16(1):37-46. PubMed ID: 22934984
[TBL] [Abstract][Full Text] [Related]
17. A click chemistry assay to identify natural product ligands for pre-microRNAs.
Garner AL; Lorenz DA; Gallagher EE
Methods Enzymol; 2019; 623():85-99. PubMed ID: 31239059
[TBL] [Abstract][Full Text] [Related]
18. Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development.
Drosopoulos K; Linardopoulos S
Methods Mol Biol; 2019; 1953():33-42. PubMed ID: 30912014
[TBL] [Abstract][Full Text] [Related]
19. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening for bioactive components from traditional Chinese medicine.
Zhu Y; Zhang Z; Zhang M; Mais DE; Wang MW
Comb Chem High Throughput Screen; 2010 Dec; 13(10):837-48. PubMed ID: 20883195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
